Jason R. Pitarresi

3.4k total citations · 2 hit papers
36 papers, 1.8k citations indexed

About

Jason R. Pitarresi is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Jason R. Pitarresi has authored 36 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Oncology, 13 papers in Molecular Biology and 9 papers in Cancer Research. Recurrent topics in Jason R. Pitarresi's work include Pancreatic and Hepatic Oncology Research (18 papers), Cancer Cells and Metastasis (7 papers) and Cancer, Hypoxia, and Metabolism (5 papers). Jason R. Pitarresi is often cited by papers focused on Pancreatic and Hepatic Oncology Research (18 papers), Cancer Cells and Metastasis (7 papers) and Cancer, Hypoxia, and Metabolism (5 papers). Jason R. Pitarresi collaborates with scholars based in United States, China and Australia. Jason R. Pitarresi's co-authors include Anil K. Rustgi, Anna M. Chiarella, Basil Bakir, Michael C. Ostrowski, Gina M. Sizemore, Subhasree Balakrishnan, Lianbo Yu, Thomas A. Mace, Thomas Ludwig and Reena Shakya and has published in prestigious journals such as Journal of Clinical Investigation, Nature Medicine and Journal of Clinical Oncology.

In The Last Decade

Jason R. Pitarresi

33 papers receiving 1.8k citations

Hit Papers

EMT, MET, Plasticity, and Tumor Metastasis 2016 2026 2019 2022 2020 2016 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. EMT, MET, Plasticity, and Tumor Metastasis
    2020 682 citations Anna M. Chiarella, Jason R. Pitarresi et al. profile →
  2. IL-6 and PD-L1 antibody blockade combination therapy reduces tumour progression in murine models of pancreatic cancer
    2016 401 citations Thomas A. Mace, Reena Shakya et al. Gut profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jason R. Pitarresi United States 15 959 830 467 358 256 36 1.8k
Christian D. Young United States 23 1.1k 1.1× 790 1.0× 420 0.9× 318 0.9× 229 0.9× 52 1.9k
Niranjan Awasthi United States 25 889 0.9× 703 0.8× 338 0.7× 231 0.6× 294 1.1× 65 1.9k
Federica Papaccio Italy 21 1.0k 1.1× 909 1.1× 594 1.3× 185 0.5× 293 1.1× 42 2.0k
Laia Caja Sweden 23 1.1k 1.1× 744 0.9× 434 0.9× 347 1.0× 164 0.6× 39 1.9k
Yaping Zong China 22 709 0.7× 664 0.8× 379 0.8× 263 0.7× 229 0.9× 47 1.4k
Eunice Y. Lau Hong Kong 20 1.1k 1.2× 624 0.8× 755 1.6× 397 1.1× 174 0.7× 37 2.0k
Long Yuan China 24 849 0.9× 640 0.8× 261 0.6× 378 1.1× 189 0.7× 56 1.7k
Silvestre Vicent Spain 24 1.1k 1.2× 721 0.9× 411 0.9× 361 1.0× 477 1.9× 40 2.0k

Countries citing papers authored by Jason R. Pitarresi

Since Specialization
Citations

This map shows the geographic impact of Jason R. Pitarresi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jason R. Pitarresi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jason R. Pitarresi more than expected).

Fields of papers citing papers by Jason R. Pitarresi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jason R. Pitarresi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jason R. Pitarresi. The network helps show where Jason R. Pitarresi may publish in the future.

Co-authorship network of co-authors of Jason R. Pitarresi

This figure shows the co-authorship network connecting the top 25 collaborators of Jason R. Pitarresi. A scholar is included among the top collaborators of Jason R. Pitarresi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jason R. Pitarresi. Jason R. Pitarresi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Johnson, Calvin W., Emma E. Furth, Karl Simin, et al.. (2025). Mitochondrial Ca2+ controls pancreatic cancer growth and metastasis by regulating epithelial cell plasticity. Cell Reports. 44(5). 115627–115627. 2 indexed citations
2.
Murphy, Katherine C., Lin Zhou, Yu-Jui Ho, et al.. (2025). MYC and p53 Alterations Cooperate through VEGF Signaling to Repress Cytotoxic T-cell and Immunotherapy Responses in Prostate Cancer. Cancer Research. 85(22). 4359–4379. 1 indexed citations
3.
Abu‐Remaileh, Muhannad, Laura Stransky, Nitin H. Shirole, et al.. (2025). Targeting of HIF2-driven cachexia in kidney cancer. Nature Medicine. 32(1). 245–257.
4.
Zhou, Lin, Katherine C. Murphy, Calvin M. Johnson, et al.. (2025). p21-Positive Senescent Stromal Cells Promote Prostate Cancer Immune Suppression and Progression That Can Be Reversed by Senolytic Therapy. Cancer Discovery. 16(3). 571–591.
5.
Myers, Paul J., Sara J. Adair, Jason R. Pitarresi, et al.. (2024). A Histone Methylation–MAPK Signaling Axis Drives Durable Epithelial–Mesenchymal Transition in Hypoxic Pancreatic Cancer. Cancer Research. 84(11). 1764–1780. 14 indexed citations
6.
Chibaya, Loretah, Katherine C. Murphy, Jason R. Pitarresi, et al.. (2024). Nanoparticle delivery of innate immune agonists combined with senescence-inducing agents promotes T cell control of pancreatic cancer. Science Translational Medicine. 16(762). eadj9366–eadj9366. 25 indexed citations
7.
Zhao, Jun, Anirban Maitra, Rohit Chandwani, et al.. (2024). FRA1 controls acinar cell plasticity during murine Kras-induced pancreatic acinar to ductal metaplasia. Developmental Cell. 59(22). 3025–3042.e7. 3 indexed citations
8.
Somarelli, Jason A., et al.. (2023). Therapeutic potential of dual CDK12 and 13 inhibition in colorectal cancer.. Journal of Clinical Oncology. 41(16_suppl). e15601–e15601. 1 indexed citations
9.
Pitarresi, Jason R. & Ben Z. Stanger. (2023). Cellular Origins and Lineage Plasticity in Cancer. Cold Spring Harbor Perspectives in Medicine. 14(6). a041389–a041389. 4 indexed citations
10.
Cho, Christina, Jinyun Chen, Farima Zahedi, et al.. (2022). Tumor-Suppressive and Immune-Stimulating Roles of Cholesterol 25-hydroxylase in Pancreatic Cancer Cells. Molecular Cancer Research. 21(3). 228–239. 15 indexed citations
11.
Chiarella, Anna M., Jason R. Pitarresi, Gulam A. Manji, & Anil K. Rustgi. (2021). Abstract 2691: Extracellular adenosine signaling in pancreatic cancer: New therapeutic strategies. Cancer Research. 81(13_Supplement). 2691–2691. 1 indexed citations
12.
Karakasheva, Tatiana A., Joel Gabre, Uma M. Sachdeva, et al.. (2021). Patient-derived organoids as a platform for modeling a patient’s response to chemoradiotherapy in esophageal cancer. Scientific Reports. 11(1). 21304–21304. 33 indexed citations
13.
Park, Dongju, Reena Shakya, Christopher S. Koivisto, et al.. (2019). Murine models for familial pancreatic cancer: Histopathology, latency and drug sensitivity among cancers of Palb2, Brca1 and Brca2 mutant mouse strains. PLoS ONE. 14(12). e0226714–e0226714. 7 indexed citations
14.
Marchand, Benoît, Jason R. Pitarresi, Maximilian Reichert, et al.. (2019). PRRX1 isoforms cooperate with FOXM1 to regulate the DNA damage response in pancreatic cancer cells. Oncogene. 38(22). 4325–4339. 26 indexed citations
15.
Chatterji, Priya, Kathryn E. Hamilton, Shun Liang, et al.. (2018). The LIN28B–IMP1 post-transcriptional regulon has opposing effects on oncogenic signaling in the intestine. Genes & Development. 32(15-16). 1020–1034. 15 indexed citations
16.
Giroux, Véronique, Mirazul Islam, Jason R. Pitarresi, et al.. (2017). Long-lived keratin 15+ esophageal progenitor cells contribute to homeostasis and regeneration. Journal of Clinical Investigation. 127(6). 2378–2391. 74 indexed citations
17.
Mace, Thomas A., Reena Shakya, Jason R. Pitarresi, et al.. (2016). IL-6 and PD-L1 antibody blockade combination therapy reduces tumour progression in murine models of pancreatic cancer. Gut. 67(2). 320–332. 401 indexed citations breakdown →
18.
Pitarresi, Jason R., et al.. (2015). Abstract B01: Ets-2 acts as a novel oncogene in cancer associated fibroblasts and promotes pancreatic tumor initiation and development. Cancer Research. 75(13_Supplement). B01–B01. 1 indexed citations
19.
Wallace, Julie A., Jason R. Pitarresi, Nandini Sharma, et al.. (2014). Protein Kinase C Beta in the Tumor Microenvironment Promotes Mammary Tumorigenesis. Frontiers in Oncology. 4. 23 indexed citations
20.
Gogada, Raghu, Honghao Zhang, Anthony Jones, et al.. (2011). Curcumin induces Apaf-1-dependent, p21-mediated caspase activation and apoptosis. Cell Cycle. 10(23). 4128–4137. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christian D. Young Breakdown of academic impact, for papers by Niranjan Awasthi Breakdown of academic impact, for papers by Federica Papaccio Breakdown of academic impact, for papers by Laia Caja Breakdown of academic impact, for papers by Yaping Zong Breakdown of academic impact, for papers by Eunice Y. Lau Breakdown of academic impact, for papers by Long Yuan Breakdown of academic impact, for papers by Silvestre Vicent
Rankless by CCL
2026